PORTFOLIO

WE TARGET HEALTHCARE ASSETS WITH SIGNIFICANT CLINICAL VALUE AND STRONG BARRIERS TO ENTRY

that are marketed by some of the world’s largest pharmaceutical companies. We also look for assets that will produce sustainable revenues over an extended period of time. Our investments span the pharmaceutical, biotechnology and specialty pharmaceutical sectors.

SPOTLIGHT

Royalty Monetization

Corporate Financing